These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8682006)

  • 41. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
    Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
    Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antianginal drugs for stable angina pectoris.
    Aronow WS
    Ration Drug Ther; 1982 Jan; 16(1):1-7. PubMed ID: 6799985
    [No Abstract]   [Full Text] [Related]  

  • 43. [Discontinuous drug release as an alternative to interval therapy in the treatment of coronary heart disease with nitroglycerin patches].
    Reiniger G; Rudolph W
    Herz; 1987 Oct; 12(5):348-53. PubMed ID: 3119443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of carvedilol in patients with impaired left ventricular function due to ischaemic heart disease.
    Lahiri A; Rodrigues EA; DasGupta P; Jain D; van der Does R; Raftery EB
    Z Kardiol; 1989; 78 Suppl 3():21-7. PubMed ID: 2573213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of coffee on exercise-induced angina pectoris due to coronary artery disease in habitual coffee drinkers.
    Piters KM; Colombo A; Olson HG; Butman SM
    Am J Cardiol; 1985 Feb; 55(4):277-80. PubMed ID: 3969861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased exercise tolerance and reduced electrocardiographic ischaemia 3 and 12 hours after oral felodipine in effort angina.
    Verdecchia P; Gatteschi C; Benemio G; Guerrieri M; Boldrini F; Pollavini G; Porcellati C
    Eur Heart J; 1989 Jan; 10(1):70-6. PubMed ID: 2702968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of anti-anginal drugs in the treatment of angina pectoris associated with silent myocardial ischemia: importance of quantitative Holter ECG data for patient activity.
    Ino-Oka E; Sagawa K; Takahashi T; Inooka H; Kutsuwa Y; Umeda S
    Intern Med; 2000 Dec; 39(12):1027-37. PubMed ID: 11197785
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sustained-release verapamil and nifedipine in exercise-induced angina pectoris.
    Foale RA; Vandenburg MJ
    Eur Heart J; 1992 Feb; 13(2):256-60. PubMed ID: 1555625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sotalol in angina pectoris. A double-blind study.
    Slome R
    S Afr Med J; 1976 Mar; 50(12):469-72. PubMed ID: 818720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antianginal and anti-ischemic efficacy of nisoldipine in stable angina pectoris: a randomized, double-blind, placebo-controlled trial.
    Chen YH; Liu RC; Wang SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):323-8. PubMed ID: 9037847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A potassium channel opener as monotherapy in chronic stable angina pectoris: comparison with placebo.
    Why HJ; Richardson PJ
    Eur Heart J; 1993 Jul; 14 Suppl B():25-9. PubMed ID: 8370369
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiotensin II-receptor antagonist losartan does not prevent nitroglycerin tolerance in patients with coronary artery disease.
    Longobardi G; Ferrara N; Leosco D; Abete P; Furgi G; Cacciatore F; Corbi G; Pescatore R; Rengo F
    Cardiovasc Drugs Ther; 2004 Sep; 18(5):363-70. PubMed ID: 15717138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A modified treadmill exercise protocol for computer-assisted analysis of the ST segment/heart rate slope: methods and reproducibility.
    Okin PM; Ameisen O; Kligfield P
    J Electrocardiol; 1986 Oct; 19(4):311-8. PubMed ID: 3540174
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ischemic threshold varies in response to different types of exercise in patients with chronic stable angina.
    Pupita G; Kaski JC; Galassi AR; J MV; Crea F; Maseri A
    Am Heart J; 1989 Sep; 118(3):539-44. PubMed ID: 2505603
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The variable effects of angiotensin converting enzyme inhibition on myocardial ischaemia in chronic stable angina.
    Simon J; Gibbs R; Crean PA; Mockus L; Wright C; Sutton GC; Fox KM
    Br Heart J; 1989 Aug; 62(2):112-7. PubMed ID: 2548548
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Slow release nifedipine plus atenolol in chronic stable angina pectoris.
    Challenor VF; Waller DG; Renwick AG; George CF
    Br J Clin Pharmacol; 1989 Nov; 28(5):509-16. PubMed ID: 2511911
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W; Tendera M; Ford I; Fox KM
    Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Long-term effect of organic nitrates in angina pectoris: dependence on the form of administration and mode of stress].
    Schneider W; Bussmann WD; Kober G; Kaltenbach M
    Z Kardiol; 1989; 78 Suppl 2():83-7; discussion 115-7. PubMed ID: 2531510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Variable responses of highly stenotic coronary arteries and collateral circulation to intracoronary injection of nitroglycerin in patients with chronic effort angina.
    Fujita M; Yamanishi K; Miwa K; Inoko M
    Coron Artery Dis; 1994 Jun; 5(6):525-9. PubMed ID: 7952412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.